The Centers for Medicare & Medicaid Services (CMS) recently issued two manufacturer releases. The first provides further information regarding the treatment of sales of authorized generic drugs in the ...
The Inflation Reduction Act’s (“IRA”) drug price negotiation provisions have captured the pharmaceutical and biotech industry’s attention. In part, the IRA allows the Centers for Medicare & Medicaid ...
Medicare offers some exceptions to beneficiaries, including formulary, tiering, and continuing employment. Generally, Medicare has set rules and regulations. However, there are times when it makes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback